TABLE OF CONTENTS
1 INTRODUCTION 35
1.1 OBJECTIVES OF THE STUDY 35
1.2 MARKET DEFINITION 35
1.3 OVERVIEW OF GLOBAL PARASITOLOGY IDENTIFICATION MARKET 35
1.4 CURRENCY AND PRICING 37
1.5 LIMITATIONS 37
1.6 MARKETS COVERED 37
2 MARKET SEGMENTATION 41
2.1 MARKETS COVERED 41
2.2 GLOBAL PARASITOLOGY IDENTIFICATION MARKET: GEOGRAPHICAL SCOPE 42
2.3 YEARS CONSIDERED FOR THE STUDY 43
2.4 CURRENCY AND PRICING 43
2.5 DBMR TRIPOD DATA VALIDATION MODEL 44
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 47
2.7 DBMR MARKET POSITION GRID 48
2.8 DBMR VENDOR SHARE ANALYSIS 50
2.9 MULTIVARIATE MODELING 51
2.10 PRODUCTS LIFELINE CURVE 51
2.11 SECONDARY SOURCES 52
2.12 ASSUMPTIONS 52
3 MARKET OVERVIEW 53
3.1 DRIVERS 55
3.1.1 INCREASING CASES OF CHRONIC AND INFECTIOUS PARASITIC INFECTIONS 55
3.1.2 TECHNOLOGIAL ADVANCEMENTS IN THE IDENTIFICATION TECHNIQUES 56
3.1.3 INCREASING R&D EXPENDITURE 57
3.1.4 GROWING GOVERNMENT INITIATIVES 58
3.2 RESTRAINTS 59
3.2.1 HIGH COST OF DEVICES 59
3.2.2 STRINGENT REGULATIONS 59
3.3 OPPORTUNITIES 60
3.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS 60
3.3.2 IMPROVING BETTER HEALTH OUTCOMES IN EMERGING COUNTRIES 61
3.4 CHALLENGE 61
3.4.1 ADOPTION OF NEW TECHNOLOGIES IN THE DEVELOPING COUNTRIES 61
4 EXECUTIVE SUMMARY 62
5 PREMIUM INSIGHTS 66
6 GLOBAL PARASITOLOGY IDENTIFICATION MARKET, BY PRODUCTS 69
6.1 OVERVIEW 70
6.2 DEVICES 71
6.2.1 FLOW CYTOMETERS 72
6.2.2 MICROARRAYS 72
6.2.3 PCR 72
6.2.4 ELISA 72
6.2.5 MASS SPECTROMETERS 72
6.2.6 POLYSTAINERS 72
6.2.7 HIGH-POWER MICROSCOPES 72
6.2.8 AUTOMATED MICROBIAL IDENTIFICATION SYSTEMS 72
6.2.9 OTHERS 72
6.3 CONSUMABLES AND ACCESSORIES 73
6.3.1 PLATES& MEDIA 73
6.3.2 REAGENTS & KITS 73
6.3.3 OTHERS 73
7 GLOBAL PARASITOLOGY IDENTIFICATION MARKET, BY METHODS 74
7.1 OVERVIEW 75
7.2 FECAL IDENTIFICATION 76
7.3 MORPHOLOGICAL IDENTIFICATION 77
7.4 MOLECULAR TECHNIQUES 77
7.5 MALDI-TOF MS 78
7.6 IMMUNOLOGICAL TECHNIQUES 79
7.6.1 HAEMAGGLUTINATION ASSAY 80
7.6.2 ELISA 80
7.6.3 OTHERS 80
7.7 RAPID DIAGNOSTIC TESTS (RDTS) 81
7.8 OTHERS 82
8 GLOBAL PARASITOLOGY IDENTIFICATION MARKET, BY PATHOGEN TYPE 83
8.1 OVERVIEW 84
8.2 PROTOZOAN 85
8.3 HELMINTHS 86
8.4 ECTOPARASITES 86
?
9 GLOBAL PARASITOLOGY IDENTIFICATION MARKET, BY SAMPLE 88
9.1 OVERVIEW 89
9.2 FECES 90
9.3 BLOOD 91
9.4 URINE 91
9.5 OTHERS 92
10 GLOBAL STOOL CONCENTRATION AND SAMPLE PREPARATION FOR PARASITOLOGY IDENTIFICATION MARKET, BY PRODUCTS 93
10.1 OVERVIEW 94
10.2 CONCENTRATION TECHNIQUE 95
10.2.1 FLOTATION TECHNIQUES 96
10.2.1.1 BRINE FLOTATION 96
10.2.1.2 SUGAR FLOTATION 96
10.2.1.3 ZINC-SULFATE FLOTATION 96
10.2.1.4 OTHERS 96
10.2.2 SEDIMENTATION TECHNIQUES 97
10.2.2.1 SIMPLE SEDIMENTATION 97
10.2.2.2 CENTRIFUGAL SEDIMENTATION 97
10.2.2.3 FORMAL-ETHYL ACETATE SEDIMENTATION/ DIPHASIC SEDIMENTATION TECHNIQUE 97
10.2.2.4 FILTRATION COMBINED WITH CENTRIFUGATION 97
10.2.2.5 DIRECT WET MOUNT 98
10.2.2.6 OTHERS 98
10.3 UNCONCENTRATION TECHNIQUE 98
11 GLOBAL PARASITOLOGY IDENTIFICATION MARKET, BY END USER 99
11.1 OVERVIEW 100
11.2 DIAGNOSTIC CENTERS 101
11.3 HOSPITALS 102
11.4 CLINICS 103
11.5 OTHERS 103
12 GLOBAL PARASITOLOGY IDENTIFICATION MARKET, BY GEOGRAPHY 104
12.1 OVERVIEW 105
12.2 NORTH AMERICA 110
12.2.1 U.S. 118
12.2.2 CANADA 122
12.2.3 MEXICO 126
?
12.3 EUROPE 130
12.3.1 GERMANY 138
12.3.2 ITALY 142
12.3.3 U.K. 146
12.3.4 FRANCE 150
12.3.5 SPAIN 154
12.3.6 NETHERLANDS 158
12.3.7 BELGIUM 162
12.3.8 SWITZERLAND 166
12.3.9 TURKEY 171
12.3.10 RUSSIA 175
12.3.11 REST OF EUROPE 179
12.4 ASIA-PACIFIC 180
12.4.1 JAPAN 188
12.4.2 CHINA 192
12.4.3 INDIA 196
12.4.4 SOUTH KOREA 200
12.4.5 AUSTRALIA 204
12.4.6 SINGAPORE 208
12.4.7 MALAYSIA 212
12.4.8 THAILAND 216
12.4.9 INDONESIA 220
12.4.10 PHILIPPINES 224
12.4.11 REST OF ASIA-PACIFIC 228
12.5 SOUTH AMERICA 229
12.5.1 BRAZIL 237
12.5.2 REST OF SOUTH AMERICA 241
12.6 MIDDLE EAST & AFRICA 242
12.6.1 SOUTH AFRICA 250
12.6.2 REST OF MIDDLE EAST & AFRICA 255
13 GLOBAL PARASITOLOGY IDENTIFICATION CONTROL MARKET, COMPANY LANDSCAPE 256
13.1 COMPANY SHARE ANALYSIS: GLOBAL 256
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 257
13.3 COMPANY SHARE ANALYSIS: EUROPE 258
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 259
?
14 SWOT ANALYSIS 260
14.1 STRENGTH 260
14.2 WEAKNESS 261
14.3 OPPORTUNITY 261
14.4 THREAT 262
14.5 DATA BRIDGE MARKET RESEARCH ANALYSIS 262
15 COMPANY PROFILE 263
15.1 ABBOTT 263
15.1.1 COMPANY SNAPSHOT 263
15.1.2 COMPANY SHARE ANALYSIS 263
15.1.3 REVENUE ANALYSIS 264
15.1.4 PRODUCT PORTFOLIO 264
15.1.5 RECENT DEVELOPMENTS 267
15.2 THERMO FISHER SCIENTIFIC INC. 268
15.2.1 COMPANY SNAPSHOT 268
15.2.2 REVENUE ANALYSIS 269
15.2.3 COMPANY SHARE ANALYSIS 269
15.2.4 PRODUCT PORTFOLIO 269
15.2.5 RECENT DEVELOPMENTS 273
15.3 SHIMADZU CORPORATION 274
15.3.1 COMPANY SNAPSHOT 274
15.3.2 REVENUE ANALYSIS 275
15.3.3 COMPANY SHARE ANALYSIS 275
15.3.4 PRODUCT PORTFOLIO 276
15.3.5 RECENT DEVELOPEMNT 277
15.4 BRUKER 279
15.4.1 COMPANY SNAPSHOT 279
15.4.2 REVENUE ANALYSIS 279
15.4.3 COMPANY SHARE ANALYSIS 280
15.4.4 PRODUCT PORTFOLIO 280
15.4.5 RECENT DEVELOPMENTS 282
15.5 BD 283
15.5.1 COMPANY SNAPSHOT 283
15.5.2 REVENUE ANALYSIS 284
15.5.3 COMPANY SHARE ANALYSIS 284
15.5.4 PRODUCT PORTFOLIO 285
15.5.5 RECENT DEVELOPMENTS 287
?
15.6 BIOMeRIEUX SA 289
15.6.1 COMPANY SNAPSHOT 289
15.6.2 REVENUE ANALYSIS 289
15.6.3 COMPANY SHARE ANALYSIS 290
15.6.4 PRODUCT PORTFOLIO 290
15.6.5 RECENT DEVELOPMENTS 291
15.7 ALTONA DIAGNOSTICS GMBH 292
15.7.1 COMPANY SNAPSHOT 292
15.7.2 PRODUCT PORTFOLIO 292
15.7.3 RECENT DEVELOPMENTS 294
15.8 BIOMERICA, INC. 295
15.8.1 COMPANY SNAPSHOT 295
15.8.2 REVENUE ANALYSIS 295
15.8.3 PRODUCT PORTFOLIO 296
15.8.4 RECENT DEVELOPMENT 296
15.9 BIO-RAD LABORATORIES, INC. 297
15.9.1 COMPANY SNAPSHOT 297
15.9.2 REVENUE ANALYSIS 297
15.9.3 PRODUCT PORTFOLIO 298
15.9.4 RECENT DEVELOPMENTS 300
15.10 CREATIVE DIAGNOSTICS 302
15.10.1 COMPANY SNAPSHOT 302
15.10.2 PRODUCT PORTFOLIO 302
15.10.3 RECENT DEVELOPMENT 303
15.11 EUROFINS SCIENTIFIC 304
15.11.1 COMPANY SNAPSHOT 304
15.11.2 REVENUE ANALYSIS 304
15.11.3 SERVICE PORTFOLIO 305
15.11.4 RECENT DEVELOPMENTS 305
15.12 LIFERIVER BIO-TECH (UNITED STATES) CORP. 306
15.12.1 COMPANY SNAPSHOT 306
15.12.2 PRODUCT PORTFOLIO 306
15.12.3 RECENT DEVELOPMENT 307
15.13 LUMINEX CORPORATION 308
15.13.1 COMPANY SNAPSHOT 308
15.13.2 REVENUE ANALYSIS 308
15.13.3 PRODUCT PORTFOLIO 309
15.13.4 RECENT DEVELOPMENTS 311
?
15.14 MERIDIAN BIOSCIENCE INC. 312
15.14.1 COMPANY SNAPSHOT 312
15.14.2 REVENUE ANALYSIS: 312
15.14.3 PRODUCT PORTFOLIO 313
15.14.4 RECENT DEVELOPMENTS 314
15.15 ORGENTEC DIAGNOSTIKA GMBH 316
15.15.1 COMPANY SNAPSHOT 316
15.15.2 PRODUCT PORTFOLIO 316
15.15.3 RECENT DEVELOPMENTS 317
15.16 R-BIOPHARM AG 318
15.16.1 COMPANY SNAPSHOT 318
15.16.2 PRODUCT CATEGORY 318
15.16.3 RECENT DEVELOPMENT 319
15.17 QUEST DIAGNOSTICS INCORPORATED 320
15.17.1 COMPANY SNAPSHOT 320
15.17.2 REVENUE ANALYSIS 320
15.17.3 PRODUCT PORTFOLIO 321
15.17.4 RECENT DEVELOPMENT 321
15.18 TECAN TRADING AG 322
15.18.1 COMPANY SNAPSHOT 322
15.18.2 REVENUE ANALYSIS 322
15.18.3 PRODUCT PORTFOLIO 323
15.18.4 RECENT DEVELOPMENTS 324
15.19 TRINITY BIOTECH 325
15.19.1 COMPANY SNAPSHOT 325
15.19.2 REVENUE ANALYSIS 325
15.19.3 PRODUCT PORTFOLIO 326
15.19.4 RECENT DEVELOPMENT 326
15.20 VIRION/SERION 327
15.20.1 COMPANY SNAPSHOT 327
15.20.2 PRODUCT PORTFOLIO 327
15.20.3 RECENT DEVELOPMENT 328
15.21 VWR INTERNATIONAL, LLC (PART OF AVANTOR) 329
15.21.1 COMPANY SNAPSHOT 329
15.21.2 PRODUCT PORTFOLIO 329
15.21.3 RECENT DEVELOPMENTS 330
?
16 QUESTIONNAIRE 331
17 CONCLUSION 335
18 RELATED REPORTS 337